DEMANT Stock Overview
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Demant A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.320.40 |
| 52 Week High | kr.373.50 |
| 52 Week Low | kr.247.90 |
| Beta | 0.91 |
| 1 Month Change | -3.44% |
| 3 Month Change | -10.90% |
| 1 Year Change | 13.22% |
| 3 Year Change | 7.26% |
| 5 Year Change | 41.15% |
| Change since IPO | 1,791.16% |
Recent News & Updates
Investors Still Waiting For A Pull Back In Demant A/S (CPH:DEMANT)
Apr 26
Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Mar 18Capital Allocation Trends At Demant (CPH:DEMANT) Aren't Ideal
Mar 06Here's Why We Think Demant (CPH:DEMANT) Is Well Worth Watching
Feb 22Recent updates
Investors Still Waiting For A Pull Back In Demant A/S (CPH:DEMANT)
Apr 26Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Mar 18Capital Allocation Trends At Demant (CPH:DEMANT) Aren't Ideal
Mar 06Here's Why We Think Demant (CPH:DEMANT) Is Well Worth Watching
Feb 22Demant (CPH:DEMANT) Has A Pretty Healthy Balance Sheet
Feb 08Demant A/S (CPH:DEMANT) Not Flying Under The Radar
Jan 22A Look At The Fair Value Of Demant A/S (CPH:DEMANT)
Jan 04At kr.302, Is Demant A/S (CPH:DEMANT) Worth Looking At Closely?
Dec 17Some Investors May Be Worried About Demant's (CPH:DEMANT) Returns On Capital
Oct 31Is Demant (CPH:DEMANT) Using Too Much Debt?
Oct 16Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 34% Above Its Share Price
Oct 01Here's What's Concerning About Demant's (CPH:DEMANT) Returns On Capital
Jul 26Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Jul 11A Look At The Fair Value Of Demant A/S (CPH:DEMANT)
Jun 26Here's Why Demant (CPH:DEMANT) Can Manage Its Debt Responsibly
Jun 13Demant (CPH:DEMANT) May Have Issues Allocating Its Capital
Apr 18Is It Too Late To Consider Buying Demant A/S (CPH:DEMANT)?
Apr 04Are Investors Undervaluing Demant A/S (CPH:DEMANT) By 25%?
Mar 21These 4 Measures Indicate That Demant (CPH:DEMANT) Is Using Debt Reasonably Well
Mar 08Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 77% Above Its Share Price
Dec 06Capital Investments At Demant (CPH:DEMANT) Point To A Promising Future
Nov 22We Think Demant (CPH:DEMANT) Can Stay On Top Of Its Debt
Oct 04Does Demant (CPH:DEMANT) Deserve A Spot On Your Watchlist?
Sep 20Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 95% Above Its Share Price
Sep 07What Is Demant A/S's (CPH:DEMANT) Share Price Doing?
Aug 19Many Would Be Envious Of Demant's (CPH:DEMANT) Excellent Returns On Capital
Jul 18Demant (CPH:DEMANT) Seems To Use Debt Rather Sparingly
Jun 22Demant A/S (CPH:DEMANT) Shares Could Be 42% Below Their Intrinsic Value Estimate
Jun 09If You Like EPS Growth Then Check Out Demant (CPH:DEMANT) Before It's Too Late
May 28Is Now The Time To Look At Buying Demant A/S (CPH:DEMANT)?
May 16Shareholders Are Optimistic That Demant (CPH:DEMANT) Will Multiply In Value
Apr 09Is Demant (CPH:DEMANT) A Risky Investment?
Mar 16Shareholders Would Not Be Objecting To Demant A/S' (CPH:DEMANT) CEO Compensation And Here's Why
Mar 03Is There An Opportunity With Demant A/S' (CPH:DEMANT) 23% Undervaluation?
Mar 01Should You Be Adding Demant (CPH:DEMANT) To Your Watchlist Today?
Feb 17What Does Demant A/S's (CPH:DEMANT) Share Price Indicate?
Feb 05Capital Investment Trends At Demant (CPH:DEMANT) Look Strong
Jan 05Does Demant (CPH:DEMANT) Have A Healthy Balance Sheet?
Dec 08Estimating The Fair Value Of Demant A/S (CPH:DEMANT)
Nov 13Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Oct 31Capital Investments At Demant (CPH:DEMANT) Point To A Promising Future
Oct 04These 4 Measures Indicate That Demant (CPH:DEMANT) Is Using Debt Safely
Sep 08Is It Time To Consider Buying Demant A/S (CPH:DEMANT)?
Jul 26Demant (CPH:DEMANT) Is Reinvesting At Lower Rates Of Return
Jun 27Is Demant (CPH:DEMANT) Using Too Much Debt?
May 31Estimating The Intrinsic Value Of Demant A/S (CPH:DEMANT)
May 03Should You Investigate Demant A/S (CPH:DEMANT) At kr.305?
Apr 19Investors Could Be Concerned With Demant's (CPH:DEMANT) Returns On Capital
Mar 23Do Its Financials Have Any Role To Play In Driving Demant A/S' (CPH:DEMANT) Stock Up Recently?
Mar 09Is Demant (CPH:DEMANT) A Risky Investment?
Feb 24Are Demant's (CPH:DEMANT) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 11
Is Demant A/S (CPH:DEMANT) Worth kr.221 Based On Its Intrinsic Value?
Jan 30Shareholder Returns
| DEMANT | DK Medical Equipment | DK Market | |
|---|---|---|---|
| 7D | -1.4% | 0.5% | 2.1% |
| 1Y | 13.2% | -3.3% | 24.5% |
Return vs Industry: DEMANT exceeded the Danish Medical Equipment industry which returned -3.4% over the past year.
Return vs Market: DEMANT underperformed the Danish Market which returned 25.7% over the past year.
Price Volatility
| DEMANT volatility | |
|---|---|
| DEMANT Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 5.7% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in DK Market | 9.9% |
| 10% least volatile stocks in DK Market | 2.8% |
Stable Share Price: DEMANT has not had significant price volatility in the past 3 months.
Volatility Over Time: DEMANT's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 21,623 | Søren Nielsen | www.demant.com |
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services.
Demant A/S Fundamentals Summary
| DEMANT fundamental statistics | |
|---|---|
| Market cap | kr.69.75b |
| Earnings (TTM) | kr.2.55b |
| Revenue (TTM) | kr.22.44b |
27.3x
P/E Ratio3.1x
P/S RatioIs DEMANT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DEMANT income statement (TTM) | |
|---|---|
| Revenue | kr.22.44b |
| Cost of Revenue | kr.5.90b |
| Gross Profit | kr.16.54b |
| Other Expenses | kr.13.99b |
| Earnings | kr.2.55b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 14, 2024
| Earnings per share (EPS) | 11.72 |
| Gross Margin | 73.72% |
| Net Profit Margin | 11.37% |
| Debt/Equity Ratio | 126.0% |
How did DEMANT perform over the long term?
See historical performance and comparison